Gene expression signature predicts rate of type 1 diabetes progression
Open Access
- 22 May 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 92, 104625
Abstract
No abstract availableKeywords
Funding Information
- Business Finland
- Leona M. and Harry B. Helmsley Charitable Trust
- Turun yliopiston tutkijakoulu
- Juvenile Diabetes Research Foundation United States of America
- Innovative Medicines Initiative
- European Research Council (310561, 314443, 329278, 335434, 335611, 341342, 677943)
- Diabetestutkimussäätiö
- Biocenter Finland
- Sigrid Juséliuksen Säätiö
- Syöpäjärjestöt (250114, 292482)
- Innovative Medicines Initiative (115797, 945268)
- Research Council of Finland
- Jane ja Aatos Erkon Säätiö
This publication has 52 references indexed in Scilit:
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosusArthritis & Rheumatism, 2010
- Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysisGenes & Immunity, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complexGenes & Immunity, 2009
- The Phagosomal Proteome in Interferon-γ-Activated MacrophagesImmunity, 2009
- Islet cell autoantibody levels after the diagnosis of young adult diabetic patientsDiabetic Medicine, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- The C4b-binding Protein-Protein S Complex Inhibits the Phagocytosis of Apoptotic CellsJournal of Biological Chemistry, 2004
- Diabetes and the Risk of Infection-Related Mortality in the U.S.Diabetes Care, 2001